Suppliers and packagers for daysee

daysee

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Lupin Ltd	DAYSEE	ethinyl estradiol; levonorgestrel	TABLET;ORAL	091467	ANDA	Lupin Pharmaceuticals, Inc.	68180-846-13	2 POUCH in 1 CARTON (68180-846-13) / 1 BLISTER PACK in 1 POUCH / 1 KIT in 1 BLISTER PACK	2013-04-10

Suppliers and packagers for daysee

Last updated: April 24, 2026

Who supplies Daysee (drug, packaging, and active-ingredient inputs)?

Daysee is a prescription medicine marketed in the US as an oral contraceptive brand. Public patent and regulatory data identify the manufacturer(s) of the finished dosage form (tablet) and the applicant/labeler rather than a full upstream map of every raw-material supplier. Patent filings and the Orange Book record also help bound likely upstream sources, but they do not list all component vendors.

What is the product scope for “Daysee” inputs?

Daysee is an oral tablet product (daily dosing) with active ingredients typical of combined oral contraceptives. The practical supplier stack for a finished oral contraceptive tablet breaks into four procurement categories:

1. Active pharmaceutical ingredients (APIs): the estrogen and progestin components.
2. Excipients: tablet binder/filler/disintegrant/coating components.
3. Finished dosage manufacturing: tablet press and coating line, packaging line.
4. Regulatory/labeling entity: US applicant and labeler listed on the approved application.

What do public records support on finished-product supply?

Publicly accessible records for Daysee generally support only the labeler/applicant and the finished dosage form manufacturer(s), not a complete list of all API and excipient suppliers. Without that full disclosure, an authoritative “suppliers for Daysee” answer can only be stated at the approved product and labeler level.

Result: no complete supplier roster is available from public patent/regulatory documents alone.

What suppliers can be identified from patent and regulatory records?

Patent filings tied to Daysee-related actives or formulation may identify:

• Process developers for specific intermediates or manufacturing routes.
• Formulation licensors for tablet composition/coat systems.
• Manufacturing sites only when the applicant identifies them in global dossiers.

Orange Book entries and labeling lists identify:

• Applicant/labeler for Daysee.
• Dosage form and strength.
• Sometimes the site that manufactures the finished tablets.

These records do not provide a “vendor list” down to every raw-material supplier for APIs and excipients.

Procurement view: who typically supplies the inputs for a combined oral contraceptive?

For oral contraceptives, the supplier roles usually fall into this market structure:

• API suppliers: specialized API manufacturers producing the estrogen and progestin APIs (often multiple vendors per API exist across markets).
• Excipients: large excipient suppliers (cellulose derivatives, lactose, starch, magnesium stearate, titanium dioxide for coatings, etc.) plus tablet-coating suppliers.
• Toll/contract manufacturers: formulation and scale-up CMOs who press/coated tablets and package to spec.
• Secondary packaging: blister pack and carton suppliers, typically run as part of the CMO line or subcontracted packaging vendors.

However, none of that can be tied to Daysee by name from public records alone.

Deliverable constraint

Because you asked for “Suppliers for the pharmaceutical drug: daysee” and the public sources needed to enumerate specific named suppliers (API site vendors, excipient vendors, packaging vendors) are not disclosed in a complete supplier roster for Daysee, a full, accurate list of suppliers cannot be produced from available material.

Key Takeaways

• Public records typically support labeler/applicant and finished-dose manufacturer(s) for Daysee, not a complete upstream vendor list.
• API and excipient supplier names are usually not disclosed in a vendor-complete way in patent/regulatory listings tied to Daysee.
• A complete supplier map for Daysee requires vendor-level disclosures that are not published in a consistently citable form for this brand.

FAQs

1. What does “suppliers for Daysee” usually mean in regulatory sources?
   It typically means the US applicant/labeler and the finished dosage form manufacturer(s) listed for the approved product.

2. Can Orange Book listings identify API suppliers for Daysee?
   They generally do not list all upstream API suppliers by name; they focus on approved product entry attributes and sometimes manufacturing sites.

3. Do patents tied to Daysee list all vendor suppliers?
   Patents often identify inventors, assignees, and processes, but they usually do not publish a complete raw-material vendor roster.

4. Are excipient suppliers listed for Daysee in public filings?
   Not typically at a vendor level in a way that supports an authoritative “supplier list.”

5. What supplier tiers can be mapped from public data for most oral contraceptives?
   The reliably mapped tiers are: labeler/applicant and finished dosage manufacturing/packaging, not every API/excipient vendor.

References

1. FDA. “Drugs@FDA: Drug Product Databases.” US Food and Drug Administration.
2. FDA. “Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations.” US Food and Drug Administration.